On Sunday, Greece approved colicin, an inexpensive drug for heart diseases, to be included in the protocol for oral treatment for patients with Kovid-19.
The Committee of Experts of the Ministry of Health gave the “green light” after the positive results of a large Canadian study, which Greece participated in.
The study showed that administration of colchicine to Kovid-19 patients “reduced mortality by 44%, hospitalization by 25% and requiring intubation by 50%,” cardiology professor Spiceros DePieros, who coordinated the study in Greece Done, told Athens-Macedonia News Agency (AMNA).
The committee decided to include the drug colicin for use in out-of-hospital patients.
However, certain categories of patients with a positive coronavirus molecular test will be administered following a prescription.
These are all patients over 60 years of age who have a positive molecular test, regardless of whether they have underlying diseases.
Also for patients aged 18 to 60 for more than 38 48 hours with at least one underlying disease or fever.
The treatment of Kovid-19 by Colocin was studied by a team of researchers from the Montreal Heart Institute.
Dr. For Jean-Claude Tardif, who led the study, it is a “major scientific discovery”, he said. Colchicine is the first “effective oral medication that treats hospital patients.”
“We are very pleased to be able to offer this to Quebec and the planet,” Tardif said.
The ColCorona study included 4,159 patients whose diagnosis of COVID-19 was confirmed by nasopharyngeal test (PCR).
Reduce congestion in hospitals
“This is the first hope for patients who have COVID, who are anxious and who hope they won’t have complications,” Tardif said. Previously, “there were no pills that could be taken by mouth and reduce the risk.”
Tardif said he believes prescribing the drug can help reduce congestion in hospitals and reduce health care costs in Quebec and elsewhere.
“Our study has shown the effectiveness of treatment with the use of colchicine to prevent the occurrence of major inflammatory storms and to reduce complications related to COVID-19,” he said.
As colchicine is a well-understood drug, it can be used to treat people with COVID-19 very quickly, the researchers say.
Talking in French, Tardif said, “Colicin is as old as – we’ve been treating gout with it for hundreds of years – so it’s available in pharmacies.”
“So any doctor, tomorrow, who reads this can certainly decide to prescribe it if he wishes.”
On Friday evening, Quebec Premier Francois Legault called the study a “big news” on the social network.